During the past decade, Derma therapy spol. s.r.o. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Derma therapy spol. s.r.o." are "Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials), "Chronic Plaque Psoriasis" (1 trials), "Dermatitis" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Derma therapy spol. s.r.o." in a lesser frequency.

Most popular intervention types in "Derma therapy spol. s.r.o." are "Drug" (3 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abrocitinib 200 mg" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Dupilumab 300 mg" (1 trials) and "Humira" (1 trials). Other intervention names were less common.

The vast majority of trials in "Derma therapy spol. s.r.o." are 4 trials for "All" genders.

Currently, there are NaN active trials in "Derma therapy spol. s.r.o.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Derma therapy spol. s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Derma therapy spol. s.r.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".